insights_auto
Por que LAURUSLABS subiu 2,06%?
Saiba maischevron_right
LAURUSLABS:NSE
Laurus Labs Ltd
₹ 2.060,10
arrow_upward
+2,06%(+41,60) 1D
16 de out., 15:30:00 GMT+5:30 · INR
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para LAURUSLABS…
Abrir
₹ 2.030,40
Alta
₹ 2.086,00
Baixa
₹ 2.028,70
Valor de mercado
1,11 tri
Volume médio
1,58 mi
Volume
1,61 mi
Dividendo
0,10%
Dividendo trimestral
₹ 0,50
Data de ex-dividendo
8 de mai. de 2026
Índice P/L
101,86
Alto — 52 sem
₹ 2.086,00
Baixo — 52 sem
₹ 870,45
LPA
₹ 20,23
Ações em circulação
106,44 mi
Nº de funcionários
7 mil
Abrir
₹ 2.030,40
Alta
₹ 2.086,00
Baixa
₹ 2.028,70
Valor de mercado
1,11 tri
Volume médio
1,58 mi
Volume
1,61 mi
Dividendo
0,10%
Dividendo trimestral
₹ 0,50
Data de ex-dividendo
8 de mai. de 2026
Índice P/L
101,86
Alto — 52 sem
₹ 2.086,00
Baixo — 52 sem
₹ 870,45
LPA
₹ 20,23
Ações em circulação
106,44 mi
Nº de funcionários
7 mil
Notícias
De fontes da web e parceiros de notícias
Stock Traders Daily
·
há 4 horas
Understanding Momentum Shifts in (AGIX)
MarketBeat
·
há 23 minutos
Scholastic (NASDAQ:SCHL) Raised to Hold at Wall Street Zen
Perfil
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Sobre Laurus Labs Ltd